Skip to main content

Closed

ATOS: Atossa Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-129.9%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio4.92×

Atossa Therapeutics, Inc.

ATOSNASDAQ Capital Market·USD·Closed

Atossa Therapeutics, Inc.

ATOSNASDAQ·USD·Closed

$2.07

−5.48%

$2.07

−$0.12 (5.48%)

52W Range

2thpctl

Volume

0.50×avg

Mkt Cap

20.65MUSD

P/E

-0.5TTM

Div Yield

–ann

52W Range

2thpctl

Volume

0.50×avg

Market Cap

20.65MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings